
Gloled Pharma Pvt Ltd
About Gloled Pharma Pvt Ltd
Data last updated:
Gloled Pharma Pvt Ltd is a private limited company based in Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 December 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR1998PTC034084. Its GSTIN is 06AABCG6671P1Z3 (Haryana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Sanjay Chopra and Kavita Chopra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 108 Mandi House Ambala City, Haryana, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.06 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹16,616 (net margin -0.4%) and EBITDA of -₹3,912 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years and 7% over five years.
As per MCA filings, the company has satisfied charges of ₹2 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gloled Pharma Pvt Ltd's registered office is in Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address108 Mandi House Ambala City, Haryana, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gloled Pharma Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gloled Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Gloled Pharma Pvt Ltd, buy the company report.
Financials of Gloled Pharma Pvt Ltd
FY 2025 filings availableGloled Pharma Pvt Ltd reported revenue of ₹46.06 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 11% fall in the latest year. EBITDA fell 128% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3,912 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16,616 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.1% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gloled Pharma Pvt Ltd, buy the company report.
Board of directors of Gloled Pharma Pvt Ltd
Gloled Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Chopra | Director | 07 Dec 1998 | 27 Years 11 Months | Current |
| Kavita Chopra | Director | 31 Mar 2014 | 12 Years 7 Months | Current |
Peer comparison
Gloled Pharma Pvt Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Esken Pharmaceuticals Limited | ₹46.28 Lakh (FY 2024) | 26.0% | Gujarat, India | |||
| Chinubhai Pharma Pvt Ltd | ₹46.16 Lakh (FY 2025) | -38.0% | Ahmedabad, Gujarat, India | |||
| Gloled Pharma Pvt Ltdthis company | ₹46.06 Lakh (FY 2025) | -₹16,616 | -0.4% | -11.0% | Haryana, India | |
| Curemart Pharma Private Limited | ₹45.79 Lakh (FY 2024) | 2066.0% | New Delhi, Delhi, India | |||
| Ctga Biopharma India Private Limited | ₹45.77 Lakh (FY 2025) | -11.0% | Hyderabad, Telangana, India | |||
| Lograns Pharma Private Limited | ₹45.53 Lakh (FY 2025) | 14.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Gloled Pharma Pvt Ltd, buy the company report.
Auditor
Gloled Pharma Pvt Ltd is audited by O P MONGIA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| O P MONGIA & ASSOCIATES | FY 2019 | 007064N |
Shareholding
The shareholding of Gloled Pharma Pvt Ltd is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Gloled Pharma Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Feb 2006 | 10000574 | Central Bank of India | ₹2 Lakh | Satisfied |
To see the full charge records of Gloled Pharma Pvt Ltd, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Gloled Pharma Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gloled Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gloled Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AABCG6671P1Z3 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gloled Pharma Pvt Ltd, buy the company report.
Recent activity
Gloled Pharma Pvt Ltd has 6 board changes on record since 1998: 2 appointments and 4 cessations. The latest: Sameer Chopra ceased to be Director on 20 Nov 2024.
Frequently asked questions
Gloled Pharma is an active private limited company based in Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 December 1998 (28+ years old) and is registered under CIN U24239HR1998PTC034084.
Gloled Pharma has 2 current directors:
- Sanjay Chopra - Director
- Kavita Chopra - Director
The latest financial statements of Gloled Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gloled Pharma is 06AABCG6671P1Z3, registered in Haryana.
The CIN (Corporate Identification Number) of Gloled Pharma is U24239HR1998PTC034084. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gloled Pharma was incorporated on 07 December 1998, making it 28+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Gloled Pharma by revenue are Esken Pharmaceuticals Limited, Chinubhai Pharma Pvt Ltd, Curemart Pharma Private Limited, Ctga Biopharma India Private Limited, Lograns Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sameer Chopra ceased to be Director on 20 Nov 2024. Pooja Chopra ceased to be Director on 18 Aug 2018. Prem Sagar Chopra ceased to be Director on 18 Aug 2018. Gloled Pharma has 6 board changes on record in total.
The registered office of Gloled Pharma is at 108 Mandi House Ambala City, Haryana, India.
Gloled Pharma operates in the pharma industry, in the drug formulation and development segment.
Gloled Pharma has no open charges and satisfied charges of ₹2 Lakh as per latest MCA filings.

